FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2201811000001108: Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25277701000001115 Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25277801000001112 Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Is a Reboxetine 4mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Is pack of Edronax 4mg tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has specific active ingredient Reboxetine mesilate true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has active ingredient Reboxetine false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has active ingredient Reboxetine mesilate false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has AMP Edronax 4mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Reboxetine false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has specific active ingredient Reboxetine mesilate false Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Edronax 4mg tablets (Pfizer Ltd) 60 tablet 3 x 20 tablets Has basis of strength substance Reboxetine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start